Roche, a Swiss pharmaceutical giant, will invest $50 billion in the United States over the next five years, creating 12,000 jobs and expanding manufacturing, distribution, and research. This decision, following a similar move by Novartis, aims to strengthen Roche’s US footprint and support innovation in medicines and diagnostics. Post navigation ‘India’s constructive engagement so far has been welcomed’: US trade body announces progress on bilateral trade deal Sustaining India’s growth requires bold reforms, Budgets have laid groundwork for this transformation: FM Sitharaman
